Abstract
Biotechnology Law ReportVol. 40, No. 1 As presented by Chris HolmanImmunex Corp. v. Sanofi-Aventis U.S. LLC United States Court of Appeals of the Federal Circuit, 202977 F.3d 1212Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN*Published Online:3 Feb 2021https://doi.org/10.1089/blr.2020.29215.cmhAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 40Issue 1Feb 2021 InformationCopyright 2021, Mary Ann Liebert, Inc., publishersTo cite this article:Immunex Corp. v. Sanofi-Aventis U.S. LLC United States Court of Appeals of the Federal Circuit, 202977 F.3d 1212.Biotechnology Law Report.Feb 2021.54-60.http://doi.org/10.1089/blr.2020.29215.cmhPublished in Volume: 40 Issue 1: February 3, 2021Online Ahead of Print:January 15, 2021PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
